Health Biotchnology Portfolio Fund Fundamentals
| SHPAX Fund | USD 20.55 0.04 0.20% |
Health Biotchnology Portfolio fundamentals help investors to digest information that contributes to Health Biotchnology's financial success or failures. It also enables traders to predict the movement of Health Mutual Fund. The fundamental analysis module provides a way to measure Health Biotchnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Health Biotchnology mutual fund.
Health |
Health Biotchnology Portfolio Mutual Fund Price To Earning Analysis
Health Biotchnology's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Health Biotchnology Price To Earning | 18.07 X |
Most of Health Biotchnology's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Health Biotchnology Portfolio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Health Biotchnology Portfolio has a Price To Earning of 18.07 times. This is much higher than that of the Saratoga family and significantly higher than that of the Health category. The price to earning for all United States funds is notably lower than that of the firm.
Health Biotchnology Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Health Biotchnology's current stock value. Our valuation model uses many indicators to compare Health Biotchnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Health Biotchnology competition to find correlations between indicators driving Health Biotchnology's intrinsic value. More Info.Health Biotchnology Portfolio is rated top fund in price to earning among similar funds. It also is rated top fund in price to book among similar funds fabricating about 0.15 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Health Biotchnology Portfolio is roughly 6.84 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Health Biotchnology's earnings, one of the primary drivers of an investment's value.Health Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Health Biotchnology's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Health Biotchnology could also be used in its relative valuation, which is a method of valuing Health Biotchnology by comparing valuation metrics of similar companies.Health Biotchnology is currently under evaluation in price to earning among similar funds.
Fund Asset Allocation for Health Biotchnology
The fund consists of 95.99% investments in stocks, with the rest of investments allocated between different money market instruments.Asset allocation divides Health Biotchnology's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Health Fundamentals
| Price To Earning | 18.07 X | |||
| Price To Book | 2.64 X | |||
| Price To Sales | 0.75 X | |||
| Total Asset | 4.78 M | |||
| Year To Date Return | 7.59 % | |||
| One Year Return | 11.64 % | |||
| Three Year Return | 4.70 % | |||
| Five Year Return | 6.09 % | |||
| Ten Year Return | 11.34 % | |||
| Net Asset | 11.88 M | |||
| Cash Position Weight | 4.01 % | |||
| Equity Positions Weight | 95.99 % |
About Health Biotchnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Health Biotchnology Portfolio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Biotchnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Biotchnology Portfolio based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.The fund will normally invest at least 80 percent of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value . Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. The Adviser utilizes a top-down investment approach focused on long-term economic trends.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Health Mutual Fund
Health Biotchnology financial ratios help investors to determine whether Health Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Biotchnology security.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |